Life science investor Linc AB plans Stockholm IPO (updated)
07/05/2021 07:08
* Plans share issue corresponding to 1.2 bln SEK
* Invests in Nordic pharmaceutical, medical technology firms
(Adds detail, background)
STOCKHOLM, May 7 (Reuters) - Swedish life science investor
Linc AB plans to list its shares on the Stockholm stock market
in the second quarter, it said on Friday.
Linc said it would carry out a new share issue corresponding
to about 1.2 billion Swedish crowns ($142.4 million).
"The company has generated a compounded annual return of
approximately 26% during the period 2010 to 2020 and intends to
use the net proceeds to continue to create value by investing in
new and existing portfolio companies," it said.
Founded in 1991 and majority-owned by Bengt Julander, Linc
says on its website that it invests primarily in pharmaceutical
and medical technology companies in the Nordic region. It has
invested in the likes of MedCap MEDCAP.ST and InDex
Pharmaceuticals INDEX.ST .
It said in the statement that the main purpose of the
listing would be to create better conditions for continued
growth, to broaden its shareholder base and provide increased
access to capital markets.
($1 = 8.4272 Swedish crowns)
(Reporting by Anna Ringstrom and Supantha Mukherjee
Editing by David Goodman
)
((anna.ringstrom@thomsonreuters.com; +46 8 502 423 74; Reuters
Messaging: anna.ringstrom.thomsonreuters.com@reuters.net))